A promising TB vaccine can be protected from heat damage with a technique developed at the University of Bath.
Scientists working on a new tuberculosis (TB) vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.
Their method prevents these crucial vaccine components from spoiling outside of a fridge – meaning a thermally stable vaccine that can be reliably delivered to remote areas around the world is more likely.
There is an urgent need not only for a new TB vaccine, but also for methods to keep vaccines stable outside of the refrigeration ‘cold chain’ – as up to 50% of vaccine doses are discarded before use due to exposure to suboptimal temperatures. Thermostable vaccines have therefore been named a priority research area in the World Health Organisation’s Global Vaccine Action Plan 2011-2020.
Ensilication, a method developed at the University of Bath, “shrink-wraps” vaccine proteins in position using layers of silica that build up into a cage around the molecules – so they don’t unravel when exposed to temperatures that would usually break them down. The proteins are held in place until ready to be removed from the silica cage and delivered.
The research team from the Departments of Biology & Biochemistry and Chemistry first demonstrated that the TB antigen ag85b and a vaccine fused with the adjuvant protein Sbi are sensitive to breaking down outside of refrigerated temperatures. They then showed that these vaccine components were protected from heat damage when ensilicated and kept on a shelf at room temperature for long periods of time without loss of structure and function.
This is first time that ensilication has been used to improve the thermal stability of proteins in a vaccine setting, after proof-of-principle work using model proteins.
The results are a big step forward not only in developing a thermally-stable TB vaccines, but in showing that ensilication could be used for many different kinds of vaccines.
The study is published in Scientific Reports
Lead author Professor Jean van den Elsen, said: “A new TB vaccine is really urgently needed to supplement or replace the existing BCG vaccine and reduce the number of TB cases and deaths – particularly as drug-resistant TB infections remain high.”
First author Ayla Wahid, added: “To make the vaccine as effective as possible it needs to be thermally-stable, or in other words not spoil outside of a fridge, which is why we’re really encouraged by these results. Cold-chain storage leads to a lot of wastage and expense which could be avoided by ensilication.”
Dr Asel Sartbaeva, who invented ensilication, added: “Our results reveal the potential of ensilication in storing and transporting life-saving vaccines at ambient temperatures globally – in particular to remote areas of developing countries where disease rates are often highest.
“With up to 50% of vaccines being thrown away, and refrigeration raising vaccine costs by up to 80%, this is a major global health challenge that we need to overcome. By demonstrating for the first time that ensilication works to protect vaccine-relevant proteins from breaking down outside a fridge we’re a big step closer to achieving this goal.”
The Latest on: TB vaccine
via Google News
The Latest on: TB vaccine
- Promising new TB prevention drug testedon August 16, 2019 at 3:28 am
The director of the SA Tuberculosis Vaccine Initiative (Satvi), Professor Mark Hatherill, said: “Although we have a licensed TB vaccine (BCG) that’s been in use for almost 100 years, it only offers ...
- A new FDA-approved drug takes aim at a deadly form of tuberculosison August 16, 2019 at 3:24 am
A. Cunningham. A new vaccine raises hopes of someday curbing the tuberculosis epidemic. Science News. Vol. 194, October 27, 2018, p. 15. N. Seppa. Poor ventilation in schools may spur TB spread.
- UNAIDS' new leader, rescissions, and breakthroughs for Ebola and TB: This week in developmenton August 15, 2019 at 12:07 pm
A health worker fills a syringe with Ebola vaccine before injecting it to a patient ... and new treatments for Ebola and drug-resistant TB provide breakthroughs: This week in development. The U.S.
- Better Therapies For TB Are Here, But They Will Not Deliver Themselveson August 15, 2019 at 4:26 am
South Africa has leveraged its strong capacity for conducting trials of new diagnostics, drugs and vaccines. Hopefully, since the Nix-TB trial included South African patients, the country will make ...
- Vaccine trial on cards for preventing TBon August 14, 2019 at 12:33 pm
The Brihanmumbai Municipal Corporation plans to diagnose and treat people with latent tuberculosis (TB) infections in an attempt to curb the spread of the disease in Mumbai. By the end of the year, ...
- New TB vaccine safe for infants, says studyon August 14, 2019 at 9:30 am
Cape Town – The South African Tuberculosis Vaccine Initiative (Satvi), biopharmaceutical company Biofabri, the University of Zaragoza in Spain and the TuBerculosis Vaccine Initiative (TBVI) announced ...
- Thermostable TB Vaccine a Huge Plus for Developing Countrieson August 9, 2019 at 5:05 am
Researchers working on a new tuberculosis (TB) vaccine say they have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage ...
- Thermally stable TB vaccine closer to reality thanks to microscopic silica cageson August 8, 2019 at 7:24 am
Scientists working on a new tuberculosis (TB) vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with ...
- New technique protects promising TB vaccine from heat damageon August 8, 2019 at 6:36 am
Scientists working on a new tuberculosis (TB) vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a ...
- Heat-stable TB Vaccine Closer to Reality By a New Techniqueon August 8, 2019 at 5:55 am
New tuberculosis (TB) vaccine adjuvant and antigen can be protected from heat damage with a technique developed at the University of Bath. The study is published in Scientific Reports. There is an ...
via Bing News